The effect of aromatic fluorine substitution in L-DOPA on the in vivo behaviour of [18F]2-, [18F]5- and [18F]6-fluoro-L-DOPA in the human brain

Raman Chirakal*, Neil Vasdev, Marie Claude Asselin, Gary J. Schrobilgen, Claude Nahmias

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Remarkable differences in the human in vivo behaviour of each of the three [18F]-labelled ring fluorinated isomers of l-dihydroxyphenylalanine (L-DOPA) are presented. Unlike [18F]2-fluoro-L-DOPA, which did not appear to cross the blood brain barrier, [18F]5-fluoro-L-DOPA appears to be taken up and cleared from the cerebellum and the striata. In contrast with the 2- and 5-fluoro isomers of L-DOPA, radioactivity derived after injection of [18F]6-fluoro-L-DOPA is specifically retained in the striata. The present study is the first direct comparison of the time course and distribution of radioactivity in the human brain after intravenous injections of [18F]2-, [18F]5- and [18F]6-fluoro-L-DOPA.

Original languageEnglish
Pages (from-to)33-39
Number of pages7
JournalJournal of Fluorine Chemistry
Volume115
Issue number1
DOIs
Publication statusPublished - 2002
Externally publishedYes

Bibliographical note

Funding Information:
We wish to thank Margo Thompson for her untiring support and Dr. Shigeko Amano for helpful discussions. N.V. and M.C.A. wish to thank the Natural Sciences and Engineering Research Council of Canada for postgraduate scholarships and the Christie Group Ltd. for awarding E.S. Garnett Bursaries in Medical Imaging.

Keywords

  • Brain uptake
  • F
  • Fluoro-L-DOPA
  • L-DOPA
  • Positron emission tomography

Fingerprint

Dive into the research topics of 'The effect of aromatic fluorine substitution in L-DOPA on the in vivo behaviour of [18F]2-, [18F]5- and [18F]6-fluoro-L-DOPA in the human brain'. Together they form a unique fingerprint.

Cite this